Condition
Pembrolizumab clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Pembrolizumab clinical trials that are recruiting, at sites in 2 countries (most in China (3), United States (1)). By phase: Phase 2 (3), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 2Countries
Newest Pembrolizumab clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Zanzalintinib plus pembrolizumab for select advanced soft-tissue sarcomas | Phase 2 | Houston, Texas | Recruiting | Dec 16, 2025 |
| Weekly paclitaxel or nab-paclitaxel with pembrolizumab and mirabegron for recurrent ovarian cancer | Phase 2 | Shanghai, Shanghai Municipality | Recruiting | Dec 3, 2025 |
| Moderate-dose radiotherapy combined with Pembrolizumab for liver cancer with blood vessel blockage | Phase 2 | Beijing, Beijing Municipality | Recruiting | Apr 29, 2024 |
| Combining Pembrolizumab with Chemotherapy for Advanced Head and Neck Cancer | Phase 3 | Beijing, Beijing Municipality | Recruiting | Oct 26, 2023 |
All recruiting trials (4)
-
Zanzalintinib plus pembrolizumab for select advanced soft-tissue sarcomas
This trial will test whether combining zanzalintinib with pembrolizumab can help control certain advanced or metastatic soft-tissue sarcomas in adults.
-
Weekly paclitaxel or nab-paclitaxel with pembrolizumab and mirabegron for recurrent ovarian cancer
This study tests whether weekly paclitaxel or nab-paclitaxel combined with pembrolizumab and daily mirabegron can shrink tumors and be safe for adults with relapsed ovarian cancer.
-
Moderate-dose radiotherapy combined with Pembrolizumab for liver cancer with blood vessel blockage
This study is testing if combining a specific type of radiation therapy with the immunotherapy drug Pembrolizumab can help people with liver cancer that has blocked blood vessels feel better and live longer.
-
Combining Pembrolizumab with Chemotherapy for Advanced Head and Neck Cancer
This study is testing whether adding a drug called pembrolizumab to standard chemotherapy can help people with advanced head and neck cancer respond better to treatment.
Related topics
Quick answers
How many Pembrolizumab clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in China (3 trials), United States (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 3, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.